Data / New clinical trials / Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung trials: 987 new

Name: New Carcinoma, Non-Small-Cell Lung clinical trials
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New Carcinoma, Non-Small-Cell Lung clinical trials: 987 rows for $49.35, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 43 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/carcinoma-non-small-cell-lung, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 9, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

987 clinical studies in Carcinoma, Non-Small-Cell Lung were first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026; 362 have an industry sponsor and 831 are recruiting or about to. The newest, NCT07926308, was posted on November 9, 2026: Real-world Outcome of Zongertinib in Japan (J-HERZ) (Boehringer Ingelheim).

The request: Every new Carcinoma, Non-Small-Cell Lung clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

987New trials
362Industry sponsored
831Recruiting or not yet
November 9, 2026Latest posted

Newest trials

The newest 100 of 987, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
November 9, 2026	NCT07926308	Real-world Outcome of Zongertinib in Japan (J-HERZ)	Boehringer Ingelheim	Observational	Not yet recruiting	Non-small Cell Lung Cancer	300	Japan	clinicaltrials.gov
November 6, 2026	NCT07922135	Moderately Hypofractionated Versus Conventional Chemoradiotherapy With Consolidation Immunotherapy in Patients With Unresectable...	Trans Tasman Radiation Oncology Group	Not applicable	Not yet recruiting	Stage III NSCLC	300		clinicaltrials.gov
November 6, 2026	NCT07921888	Patient-Specific MRD Liquid Biopsy in Resected NSCLC: Plasma and Bronchial Washing ctDNA	Eun Hye Lee	Observational	Recruiting	Non-Small Cell Lung Cancer, Minimal Residual Disease	40	South Korea	clinicaltrials.gov
November 6, 2026	NCT07920822	Evaluation of the I-phase Clinical Trial of 177Lu-HX02 Injection in Patients With Advanced Malignant Solid Tumors	Hexin (Suzhou) Pharmaceutical Technology Co., Ltd	Phase 1	Enrolling by invitation	Soft Tissue Sarcoma, Non-small Cell Lung Cancer	12	China	clinicaltrials.gov
November 5, 2026	NCT07919691	Proton Moderately Hypofractionated Radiotherapy in NSCLC Patients Unable to Tolerate Standard Concurrent Chemoradiotherapy	Ruijin Hospital	Phase 2	Not yet recruiting	Non-Small Cell Lung Cancer	44		clinicaltrials.gov
November 5, 2026	NCT07917767	A Prospective Cohort Study of PD-1 Monoclonal Antibody Combined With Ipilimumab N01 and Chemotherapy in Perioperative Treatment of...	Tang-Du Hospital	Phase 2	Not yet recruiting	NSCLC Stage IIIA/B, NSCLC Stage II	90		clinicaltrials.gov
November 4, 2026	NCT07916129	Single-center Transformational Study on Feasibility and Efficacy of Respiratory Motion Management Using Novel Position Fixation Device for...	Tianjin Medical University Cancer Institute and Hospital	Not applicable	Enrolling by invitation	Non-Small Cell Carcinoma of Lung	50	China	clinicaltrials.gov
November 4, 2026	NCT07914972	Treatment Pattern and Patient Outcomes Among Stage I-II Unresected NSCLC Patients	AstraZeneca	Observational	Not yet recruiting	Non-small Cell Lung Cancer, NSCLC, Stage I-II Unresected NSCLC	440		clinicaltrials.gov
November 3, 2026	NCT07912593	Phase 1/2, Open-label Study of ETX-929, a KRAS Inhibitor in Participants With Advanced Solid Tumors	Ensem Therapeutics	Phase 1/2	Recruiting	Metastatic Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Non-squamous, Non-Small Cell Lung Cancer...	320	United States	clinicaltrials.gov
November 3, 2026	NCT07912268	Study of SIM0518 in Participants With ALK-Positive or ROS1-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer	Jiangsu Simcere Pharmaceutical Co., Ltd.	Phase 1	Not yet recruiting	ALK-Positive or ROS1-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer	270	China	clinicaltrials.gov
November 2, 2026	NCT07911449	Osimertinib Plus Stereotactic Radiosurgery/Radiotherapy for EGFR-Mutant Non-Small Cell Lung Cancer With Symptomatic Brain Metastases	Cho Ray Hospital	Phase 2	Recruiting	Non-Small Cell Lung Cancer, Brain Metastases From Non-small Cell Lung Cancer (NSCLC), EGFR Activating Mutation	41	Vietnam	clinicaltrials.gov
November 2, 2026	NCT07911267	Development and Utilization of an Integrated Clinical Genomic Database	Samsung Medical Center	Observational	Recruiting	Gastric Cancer, Colorectal Cancer, Lung Cancer (NSCLC), Liver Cancer, Pancreatic Cancer	118,750	South Korea	clinicaltrials.gov
November 2, 2026	NCT07910942	A Phase 1 Trial of KAN-001 With Pembrolizumab, With or Without Chemotherapy, in Participants With PD-L1-Positive Non-Small Cell Lung Cancer	Kanvas Biosciences	Phase 1	Not yet recruiting	Non-Small Cell Lung Cancer	40	Canada, United States	clinicaltrials.gov
November 2, 2026	NCT07909343	Patient Needs and Preferences for NSCL Cancer Treatment Monitoring	European Institute of Oncology	Observational	Recruiting	Lung Cancer (NSCLC)	35	Italy	clinicaltrials.gov
November 2, 2026	NCT07909031	CR-002 in Adult Participants With Locally Advanced or Metastatic Solid Tumors	Crescent Biopharma, Inc.	Phase 1/2	Recruiting	Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M), Gastric/GEJ, Biliary Tract Cancer (BTC)...	219	United States	clinicaltrials.gov
November 2, 2026	NCT07908745	Reduced-Dose vs Standard-Dose Thoracic Radiotherapy After Induction Chemoimmunotherapy in Older or Frail Stage III NSCLC	Ruijin Hospital	Phase 3	Not yet recruiting	Non-Small-Cell Lung Cancer	276		clinicaltrials.gov
November 2, 2026	NCT07908732	Risk-Adapted Segmental Esophagus-Sparing Radiotherapy for Definitive Non-Small Cell Lung Cancer	Ruijin Hospital	Phase 3	Not yet recruiting	Non-Small Cell Lung Cancer	140		clinicaltrials.gov
October 30, 2026	NCT07906626	Snakehead Fish Extract and Curcumin Co-Supplementation in Advanced Lung Cancer on Inflammation, Nutritional Status, and Quality of Life	Universitas Sumatera Utara	Not applicable	Completed	Lung Cancer (NSCLC)	60	Indonesia	clinicaltrials.gov
October 30, 2026	NCT07906158	PET/CT-Based Intratumoral Heterogeneity and Multimodal Imaging for Tumor Diagnosis and Prognosis	Shengjing Hospital	Observational	Completed	Solid Neoplasms, Non-Small Cell Lung Cancer	900	China	clinicaltrials.gov
October 29, 2026	NCT07904013	Impact of a Radiologic and Immunologic Signature on Cerebral Efficacy of Treatments in Lung Cancers With Brain Metastasis	University Hospital, Bordeaux	Observational	Not yet recruiting	Carcinoma, Non-Small-Cell Lung, Brain Neoplasms, Neoplasm Metastasis	38	France	clinicaltrials.gov
October 29, 2026	NCT07903415	A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors.	Pfizer	Phase 1	Recruiting	Pancreatic Ductal Adenocarcinoma, Esophageal Cancer, Carcinoma, Non-Small-Cell Lung (NSCLC), Gastric Carcinoma...	280	United States	clinicaltrials.gov
October 29, 2026	NCT07902921	STAR0602 With Nivolumab in Non Small Cell Lung Cancer and in Metastatic Castrate-Resistant Prostate Cancer, and STAR0602 Alone in Thymic...	National Cancer Institute (NCI)	Phase 1/2	Not yet recruiting	NSCLC, Non-Small Cell Lung Cancer, Lung Cancer, Prostate Cancer, Thymic Epithelial Tumors, TETs, Thymic Carcinomas...	67	United States	clinicaltrials.gov
October 28, 2026	NCT07900581	Analysis of Whole Exome and Transcriptome Sequencing to Identify Prognostic Biomarkers in Patients With Non-Small Cell Lung Cancer (NSCLC)	Hellenic Cooperative Oncology Group	Observational	Recruiting	Non-small Cell Lung Cancer (NSCLC)	300	Cyprus, Greece	clinicaltrials.gov
October 28, 2026	NCT07899801	A Phase 1a/1b Of Zanidatamab In Combination With Zongertinib In HER2-Mutated Non-Small Cell Lung Cancer (NSCLC)	M.D. Anderson Cancer Center	Phase 1	Not yet recruiting	Non Small Cell Lung Cancer	24	United States	clinicaltrials.gov
October 27, 2026	NCT07899086	A Phase I Study of HS-20093 Injection in Combination Therapy in Non-Small Cell Lung Cancer	Hansoh BioMedical R&D Company	Phase 1	Not yet recruiting	Non-Small Cell Lung Cancer	102		clinicaltrials.gov
October 27, 2026	NCT07898241	Using an Artificial Intelligence Software Tool (iSeg) During Radiation Treatment Planning for Patients With Lung Tumors	Northwestern University	Not applicable	Not yet recruiting	Lung Carcinoma, Lung Non-Small Cell Carcinoma, Metastatic Malignant Neoplasm in the Lung	34	United States	clinicaltrials.gov
October 27, 2026	NCT07897019	Efficacy and Safety of Almonertinib Combined With Recombinant Human Endostatin in the Treatment of Stage IIIB-IV Non-small Cell Lung Cancer	Three Gorges Hospital of Chongqing University	Observational	Terminated	Non-Small Cell Lung Cancer	1	China	clinicaltrials.gov
October 26, 2026	NCT07896005	A Study of SHR-A1811 Combined With Adebrelimab for the First-line HER2-overexpressing Non-squamous Non-small Cell Lung Cancer	Suzhou Suncadia Biopharmaceuticals Co., Ltd.	Phase 3	Not yet recruiting	Non Small Cell Lung Cancer	436	China	clinicaltrials.gov
October 26, 2026	NCT07895238	A Study of Perioperative Adebrelimab Plus Chemotherapy Versus Adjuvant Therapy in Patients With Resectable NSCLC	West China Hospital	Phase 3	Not yet recruiting	Non-small Cell Lung Cancer (NSCLC)	1,088		clinicaltrials.gov
October 26, 2026	NCT07894874	A Study to Evaluate YF550 in Participants With Locally Advanced or Metastatic Solid Tumors.	InventisBio Yiqi Beijing Limited	Phase 1	Not yet recruiting	Solid Tumor (Phase I), Ovarian Cancer, NSCLC (Advanced Non-small Cell Lung Cancer), TNBC - Triple-Negative Breast Cancer	204		clinicaltrials.gov
October 26, 2026	NCT07894367	Gematinib Combined With Lenvatinib for the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer With MET Protein...	Peking University Cancer Hospital & Institute	Phase 2	Not yet recruiting	Non-Small Cell Lung Cancer	23		clinicaltrials.gov
October 23, 2026	NCT07892300	Implantable Microdevices for in Situ Evaluation of Drug Responses in Lung Cancer	Oliver Jonas	Early phase 1	Not yet recruiting	Lung Cancer, Mesothelioma, Suspected Lung Cancer, Suspected Mesothelioma	20		clinicaltrials.gov
October 22, 2026	NCT07890714	A Study of Dato-DXd in Participants With Solid Tumors [TROPION-PanTumor04 (TP04)]	Daiichi Sankyo	Phase 1/2	Recruiting	Urothelial Cancer, Non-small Cell Lung Cancer	268	Taiwan	clinicaltrials.gov
October 22, 2026	NCT07890636	Adebrelimab Plus Famitinib as Adjuvant Therapy in Non-pCR NSCLC	Ruijin Hospital	Phase 2	Not yet recruiting	Lung Neoplasm Malignant	64	China	clinicaltrials.gov
October 22, 2026	NCT07890493	Immune Checkpoint Blockade and Chemotherapy With or Without Fecal Microbiota Transplant in Advanced Non-Small Cell Lung Cancer	Canadian Cancer Trials Group	Phase 2	Not yet recruiting	Non Small Cell Lung Cancer	160		clinicaltrials.gov
October 22, 2026	NCT07890246	A Phase 1 Study of IM-1340 in Participants With Advanced Cancer	Immunome, Inc.	Phase 1	Not yet recruiting	Colorectal Cancer, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Neuroendocrine Neoplasm	200		clinicaltrials.gov
October 22, 2026	NCT07890038	The Clinical Application Value of CAIX-Targeted PET Hypoxia Imaging in Malignant Tumors	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Observational	Active not recruiting	Nasopharyngeal Cancers, Lung Cancer (NSCLC), Esophageal Cancer, Glioma	50	China	clinicaltrials.gov
October 22, 2026	NCT07889297	Pulsed Field Ablation for the Treatment of Malignant Lung Tumors	Shanghai Chest Hospital	Not applicable	Not yet recruiting	Non-Small Cell Lung Cancer, Pulmonary Metastases	15	China	clinicaltrials.gov
October 22, 2026	NCT07889232	Tocilizumab Combined With First-Line Chemo-Immunotherapy in Metastatic Non-Small Cell Lung Cancer	VA Office of Research and Development	Phase 1/2	Not yet recruiting	Metastatic Non-Small Cell Lung Cancer, Cancer-Associated Weight Loss, Elevated Inflammatory Markers	43	United States	clinicaltrials.gov
October 22, 2026	NCT07888075	Master Protocol for the Study of Rilogrotug for the Treatment of Weight Loss and Anorexia in Patients With Cancer Cachexia and mCRC or...	AVEO Pharmaceuticals, Inc.	Phase 2/3	Not yet recruiting	Cachexia; Cancer, Cachexia, Cachexia-Anorexia Syndrome, Metastatic Colorectal Cancer (CRC), Metastatic Non-small Cell...	950		clinicaltrials.gov
October 22, 2026	NCT07887971	A Study of [225Ac]Ac-AKY-2519 in Patients With B7-H3 Expressing Solid Tumors	Aktis Oncology, Inc.	Phase 1	Recruiting	NSCLC, NSCLC (Advanced Non-small Cell Lung Cancer), ES-SCLC, Small Cell Lung Cancer Extensive Stage, B7H3, Prostate...	152	United States	clinicaltrials.gov
October 21, 2026	NCT07886359	Effects of Supervised Aerobic Exercise on Biomarkers in Patients With nSCLC Receiving Immunotherapy	Izmir Bakircay University	Not applicable	Not yet recruiting	Non-Small Cell Lung Cancer, Aerobic Exercise, Immunotherapy, Biomarker, Tumor Microenvironment, Handgrip Strength...	78		clinicaltrials.gov
October 21, 2026	NCT07886229	Propranolol Hydrochloride Combined With Toripalimab and Platinum-based Chemotherapy in Resectable Non-Small Cell Lung Cancer	Second Xiangya Hospital of Central South University	Phase 1	Recruiting	Resectable Non-Small-Cell Lung Cancer	9	China	clinicaltrials.gov
October 21, 2026	NCT07885709	MRD and Imaging Guided Adaptive Neoadjuvant Therapy for Resectable NSCLC	Peking University People's Hospital	Phase 2	Not yet recruiting	Non-Small Cell Lung Cancer (NSCLC)	100	China	clinicaltrials.gov
October 20, 2026	NCT07882940	Becotatug Vedotin + Pucotenlimab+Platinum Induction and Sequential CCRT for Unresectable LA NSCLC	Sun Yat-sen University	Phase 2	Not yet recruiting	Non-Small Cell Carcinoma of Lung, Locally Advanced	24		clinicaltrials.gov
October 19, 2026	NCT07880106	Multimodal Liquid-Biopsy Omics Biomarkers of Treatment Response in Breast Cancer	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	Observational	Not yet recruiting	Lung Cancer Non-small Cell, Colorectal Cancer, Stomach Cancer, Hepatocellular Carcinoma, Breast Cancer	2,000	China	clinicaltrials.gov
October 19, 2026	NCT07879768	Acupuncture and Laser Acupuncture for Advanced Non-Small Cell Lung Cancer	China Medical University, Taiwan	Not applicable	Not yet recruiting	Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung	90	Taiwan	clinicaltrials.gov
October 16, 2026	NCT07877584	PD-1 Blockade Alone Versus in Combination With Chemotherapy as First Line Therapy in Females With Advanced NSCLC & PD-L1 Expression ≥50%	German Cancer Research Center	Phase 3	Not yet recruiting	Non-Small Cell Lung Cancer	406		clinicaltrials.gov
October 15, 2026	NCT07875465	Intestinal Low-Dose Radiotherapy Combined With Immune Checkpoint Inhibitors in Solid Tumors With Liver Metastases	Bing Xia	Phase 2	Not yet recruiting	Liver Metastases, Non-Small Cell Lung Cancer, Colorectal Cancer (Diagnosis), Pancreatic Cancer Metastatic, Solid Tumors	120	China	clinicaltrials.gov
October 15, 2026	NCT07874984	SPGL008 in Combination With SSGJ-706 ± Chemotherapy for Advanced Non-small Cell Lung Cancer	Shenyang Sunshine Pharmaceutical Co., LTD.	Phase 2	Not yet recruiting	Non Small Cell Lung Cancer	220		clinicaltrials.gov
October 15, 2026	NCT07874490	Osimertinib and Cyclosporine A to Enhance Antitumor Efficacy in NSCLC	NYU Langone Health	Phase 2	Recruiting	Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor	60	United States	clinicaltrials.gov
October 14, 2026	NCT07874464	Prospective Phase II Study of Concurrent Radiotherapy Combined With Full-Course Immunotherapy or Consolidation Immunotherapy for Locally...	Sun Yat-sen University	Phase 2	Not yet recruiting	Lung Cancer (NSCLC)	256	China	clinicaltrials.gov
October 14, 2026	NCT07873450	SumMET: Study of [225Ac]Ac-FL-261 in Participants With Solid Tumors Overexpressing c-MET	Full-Life Technologies UK Limited	Phase 1/2	Recruiting	Solid Tumor, NSCLC, Colorectal Cancer, Head and Neck Cancer, Cholangiocarcinoma	208	Australia, United States	clinicaltrials.gov
October 14, 2026	NCT07873086	MRD-Guided Aumolertinib-Based Adjuvant Therapy for Resected EGFR-Mutant NSCLC	Peking University People's Hospital	Not applicable	Not yet recruiting	Non-Small Cell Lung Cancer	50	China	clinicaltrials.gov
October 13, 2026	NCT07871214	A Study to Assess The Safety and Tolerability of Pumitamig-Based Therapy Administered Before Surgery in Participants With Early-Stage...	Bristol-Myers Squibb	Phase 2	Not yet recruiting	Early-Stage Non-Small Cell Lung Cancer	80	Australia, Canada, China, France, Germany, Italy, Japan, Poland, Romania, South...	clinicaltrials.gov
October 9, 2026	NCT07869329	Biomarker Testing to Predict Radiation-Related Heart Disease in Lung Cancer Patients	Duke University	Not applicable	Not yet recruiting	Non-Small Cell Lung Cancer, Radiation-Induced Cardiac Disease	50	United States	clinicaltrials.gov
October 9, 2026	NCT07869186	Dermatological Effects and Quality of Life in Oncology Patients	European Institute of Oncology	Not applicable	Not yet recruiting	Breast Cancer, Ovarian Cancer, NSCLC (Non-small Cell Lung Cancer), Melanoma (Skin Cancer), Gynecological Cancer	300	Italy	clinicaltrials.gov
October 8, 2026	NCT07865910	A Study to Learn the Safety and Efficacy of HLX37 in Combination With Chemotherapy for First-line Treatment in Adult Participants With...	Shanghai Henlius Biotech	Phase 2/3	Not yet recruiting	NSCLC (Advanced Non-small Cell Lung Cancer)	1,438	China	clinicaltrials.gov
October 8, 2026	NCT07864584	Study Using a Drug-device Combination Product to Determine Safety, Tolerability and Antitumor Activity for Patients With Advanced...	Nob Hill Therapeutics, Inc.	Phase 1/2	Not yet recruiting	NSCLC (Advanced Non-small Cell Lung Cancer)	100	United States	clinicaltrials.gov
October 7, 2026	NCT07863167	An Open, Multicenter Phase II Clinical Trial of SHR-A2009 Combined With Other Anti-tumor Therapies for Perioperative Treatment of...	Suzhou Suncadia Biopharmaceuticals Co., Ltd.	Phase 2	Not yet recruiting	Non-small Cell Lung Cancer	660	China	clinicaltrials.gov
October 7, 2026	NCT07863024	Safety and Efficacy Study in Adults With Advanced Solid Tumors Receiving REGN13089-M404-M2980, an Antibody-drug Conjugate That Targets MET...	Regeneron Pharmaceuticals	Phase 1/2	Not yet recruiting	Advanced Solid Tumors	320		clinicaltrials.gov
October 5, 2026	NCT07857694	Thoracic Radiotherapy Plus EGFR-TKI for Stage III EGFR-mutant Lung Adenocarcinoma	Laibin People's Hospital	Observational	Completed	Lung Cancer Stage III, EGFR Activating Mutation	202	China	clinicaltrials.gov
October 5, 2026	NCT07857616	SI-B036-ST-101 in Advanced/Metastatic Solid Tumors	SystImmune Inc.	Phase 1	Recruiting	Locally Advanced /Metastatic Solid Tumors, Locally Advanced / Metastatic Solid Tumors, Metastatic Solid Cancers, Non...	424	United States	clinicaltrials.gov
October 2, 2026	NCT07855965	Multicenter, Single-Arm, Prospective Phase II Study of Neoadjuvant Cryo-Thermal Ablation Combined With Toripalimab and Chemotherapy for...	West China Hospital	Phase 2	Recruiting	Carcinoma, Non-Small-Cell Lung (NSCLC)	40	China	clinicaltrials.gov
October 2, 2026	NCT07854769	Blood Testing to Detect Cancer Recurrence in Patients With Early-Stage Non-Small Cell Lung Cancer	Fox Chase Cancer Center	Observational	Not yet recruiting	Non Small Cell Lung Cancer	200		clinicaltrials.gov
September 30, 2026	NCT07849712	An Exploratory Clinical Study Of Bempemab Combined With Anlotinib As First-Line Treatment For Elderly Patients With Locally Advanced Or...	Zhejiang Cancer Hospital	Not applicable	Not yet recruiting	Non-small Cell Lung Cancer (NSCLC) Stage IV, Locally Advanced Non-Small Cell Lung Cancer, Metastatic Non-small Cell...	30	China	clinicaltrials.gov
September 29, 2026	NCT07848243	Clinical Investigator-Initiated Trial (IIT) of PD-L1-Targeted Radionuclide Probes	Peking University Cancer Hospital & Institute	Phase 2	Recruiting	Lung Cancer (NSCLC), Cervical Squamous Cell Cancer, Melanoma (Skin Cancer), Breast Cancer, Gastrointestinal Cancers	50	China	clinicaltrials.gov
September 29, 2026	NCT07846358	This is a Multicenter, Open-label, Phase I/II Study to Explore the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Efficacy of...	Genfleet Therapeutics (Shanghai) Inc.	Phase 1/2	Not yet recruiting	RAS Mutation, Non-small Cell Lung Cancer (NSCLC)	84		clinicaltrials.gov
September 29, 2026	NCT07845916	Quad Shot Radiotherapy Combined With Tislelizumab and Platinum-Based Chemotherapy Before Surgery for Stage II-III Non-Small Cell Lung Cancer	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Phase 2	Not yet recruiting	Non-Small Cell Lung Cancer	12	China	clinicaltrials.gov
September 25, 2026	NCT07842471	Local Consolidative Therapy Versus Maintenance Immunotherapy After First-Line Chemoimmunotherapy in Metastatic NSCLC	Guangdong Provincial People's Hospital	Phase 2	Not yet recruiting	NSCLC (Non-small Cell Lung Carcinoma)	117	China	clinicaltrials.gov
September 25, 2026	NCT07841249	Cardiorespiratory Fitness After Lobectomy Versus Sublobar Resection	Tongji Hospital	Observational	Recruiting	Lung Cancer (NSCLC)	604	China	clinicaltrials.gov
September 25, 2026	NCT07841106	Early Prophylactic Versus Late Salvage Recombinant Human Endostatin in Managing Radiosurgery-Induced Brain Injury for NSCLC Brain Metastases	Jiangmen Central Hospital	Phase 2	Not yet recruiting	Lung Cancer (Non-Small Cell), Radiation, Brain Injury, Brain Edema, Brain Necrosis	49		clinicaltrials.gov
September 24, 2026	NCT07838532	Real-World Study of Aumolertinib in Patients With Advanced EGFR T790M-Positive NSCLC	Xin Li	Observational	Completed	Non Small Cell Lung Cancer, T790M, EGFR Activating Mutation	637	China	clinicaltrials.gov
September 23, 2026	NCT07837739	Adjuvant EGFR-TKI Therapy After Surgery for EGFR-Mutant High-Risk Stage IA2-IIB NSCLC	Tongji Hospital	Observational	Recruiting	Non-Small Cell Lung Cancer	100	China	clinicaltrials.gov
September 23, 2026	NCT07836543	Trastuzumab Rezetecan and Adebrelimab, Alone or in Combination, After Chemoradiotherapy for HER2-Altered Unresectable Stage III Lung Cancer	Ming Chen	Phase 2	Not yet recruiting	Non-Small Cell Lung Cancer	105		clinicaltrials.gov
September 22, 2026	NCT07833085	CAIX-targeted PET/CT in Solid Tumors	Zhongnan Hospital	Not applicable	Recruiting	Malignant Solid Tumors, Clear Cell Renal Cell Carcinoma, Lung Cancer (NSCLC), Breast Cancer	100	China	clinicaltrials.gov
September 21, 2026	NCT07829744	Perioperative Targeted Therapy in Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer With Rare Driver Mutations	Shanghai Zhongshan Hospital	Phase 2	Not yet recruiting	Lung Cancer (NSCLC)	190		clinicaltrials.gov
September 18, 2026	NCT07828938	Short- and Mid-term Therapeutic, Prognostic, and Societal Impact of Implementing Intraoperative Assessment of Pulmonary Resection Quality...	Fondation Hôpital Saint-Joseph	Not applicable	Not yet recruiting	Lung Cancer (Non-Small Cell)	2,400	France	clinicaltrials.gov
September 18, 2026	NCT07827885	20-Fr Versus 24-Fr Chest Drains After Uniportal VATS Lobectomy for NSCLC	Fondazione Policlinico Universitario Campus Bio-Medico	Not applicable	Completed	Non-Small Cell Lung Cancer	80	Italy	clinicaltrials.gov
September 18, 2026	NCT07827261	A Study of BL-B01D1 Combined With Glecirasib in Patients With KRAS G12C-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer	Sichuan Baili Pharmaceutical Co., Ltd.	Phase 2	Not yet recruiting	Non-small Cell Lung Cancer	36	China	clinicaltrials.gov
September 17, 2026	NCT07824882	A Phase II Study of HS-20093 Injection Combined With Adebrelimab Versus HS-20093 Injection in Previously Treated Patients With Advanced or...	Hansoh BioMedical R&D Company	Phase 2	Recruiting	Non-Small Cell Lung Cancer	76	China	clinicaltrials.gov
September 17, 2026	NCT07824778	Construction and Application Research of a Multidisciplinary Combined Exercise Management Program for Elderly Lung Cancer Patients After...	Sir Run Run Shaw Hospital	Not applicable	Completed	Lung Cancer (NSCLC)	68	China	clinicaltrials.gov
September 16, 2026	NCT07823855	SIB Accelerated Hyperfractionated RT for High-Proliferation NSCLC	Second Affiliated Hospital, Zhejiang University, School of Medicine	Not applicable	Recruiting	Non-Small Cell Lung Cancer	15	China	clinicaltrials.gov
September 16, 2026	NCT07823725	TailorDose Lung: Decentralized TDM of Taxanes and ALK Inhibitors Using Capillary Self-Sampling	Karolinska Institutet	Not applicable	Not yet recruiting	Non-Small Cell Lung Cancer (MeSH Term: Carcinoma, Non-Small-Cell Lung)	40	Sweden	clinicaltrials.gov
September 16, 2026	NCT07822984	Consolidative Stereotactic Radiotherapy for Oligo-Residual Advanced EGFR-Mutant NSCLC After First-Line Third-Generation EGFR-TKI Plus...	Fudan University	Phase 2	Not yet recruiting	EGFR-mutant Non-small Cell Lung Cancer, SBRT, NSCLC (Advanced Non-small Cell Lung Cancer)	374		clinicaltrials.gov
September 16, 2026	NCT07822880	A Study of Selpercatinib (LY3527723) in Participants With Rearranged During Transfection (RET)-Altered Cancers in India	Eli Lilly and Company	Phase 4	Not yet recruiting	Thyroid Neoplasms, Carcinoma, Non-Small-Cell Lung	30	India	clinicaltrials.gov
September 16, 2026	NCT07822542	A Study Evaluating HS-10370 Plus Platinum-based Doublet Chemotherapy With or Without Adebrelimab vs. Tislelizumab Plus Chemotherapy as...	Jiangsu Hansoh Pharmaceutical Co., Ltd.	Phase 3	Not yet recruiting	Carcinoma, Non-Small-Cell Lung	448		clinicaltrials.gov
September 16, 2026	NCT07821684	A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan Compared to Standard of Care in Adult Participants Previously Treated, EGFR...	AbbVie	Phase 3	Not yet recruiting	Non-Squamous Non-Small Cell Lung Cancer	660		clinicaltrials.gov
September 15, 2026	NCT07819578	Toripalimab Plus Sacituzumab Tirumotecan as Neoadjuvant Therapy for Resectable NSCLC	Shaodong Hong	Phase 2	Not yet recruiting	Non-Small Cell Lung Cancer	30		clinicaltrials.gov
September 14, 2026	NCT07818304	SRT Combined With Envafolimab and Endostar in the First-line Treatment of Advanced NSCLC	The First People's Hospital of Lianyungang	Phase 2	Not yet recruiting	Non Small Cell Lung Cancer, Lung Neoplasms	61	China	clinicaltrials.gov
September 14, 2026	NCT07818135	Comparison of Biportal Versus Multiportal Robotic Approaches for Pulmonary Resection in NSCLC	Carlos Déniz	Not applicable	Recruiting	Non-Small Cell Lung Cancer	80	Spain	clinicaltrials.gov
September 14, 2026	NCT07817329	NUT Project: Nutritional Support in Thoracic Oncology	Casa di Cura Dott. Pederzoli	Observational	Recruiting	Oncologic Diseases, Lung Cancer (NSCLC)	100	Italy	clinicaltrials.gov
September 11, 2026	NCT07816380	A Phase III Study to Evaluate the Efficacy and Safety of JYP0322 in Previously Untreated ROS1-Positive Locally Advanced or Metastatic...	Guangzhou JOYO Pharma Co., Ltd	Phase 3	Not yet recruiting	NSCLC (Advanced Non-small Cell Lung Cancer)	216		clinicaltrials.gov
September 11, 2026	NCT07815873	Gut Microbiome in Patients With Lung and Melanoma Cancer and Intestinal Microbiota in Gynecologic Cancers	European Institute of Oncology	Not applicable	Not yet recruiting	Non Small Cell Lung Cancer, Melanoma (Skin Cancer), Endometrial Cancer, Cervical Cancer	360	Italy	clinicaltrials.gov
September 10, 2026	NCT07814248	A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a...	TwoStep Therapeutics, Inc.	Phase 1	Recruiting	NSCLC (Non-small Cell Lung Cancer), HNSCC, Endometrial, Ovarian Cancer, Esophageal Cancer, Head & Neck Cancer, Gastric...	74	United States	clinicaltrials.gov
September 9, 2026	NCT07809763	Wireless Wearable Home Prehabilitation for Older Adults With NSCLC	West China Hospital	Not applicable	Recruiting	Non-Small Cell Lung Cancer (NSCLC), Rehabilitation, Thoracic Surgery, Prehabilitation	196	China	clinicaltrials.gov
September 9, 2026	NCT07809256	A Prospective, Single-center, Non-randomized, Interventional Study on the Effectiveness and Safety of Combined Immunotargeted Therapy in...	EuroCityClinic LLC	Phase 3	Recruiting	NSCLC (Non-small Cell Lung Cancer)R	15	Russia	clinicaltrials.gov
September 8, 2026	NCT07808138	RADICAL-IO: thRee Cycles of immunotherApy Without raDical Therapy In mediCALly InOperable Stage I Non-small Cell Lung Cancer	The Netherlands Cancer Institute	Phase 2	Not yet recruiting	Non Small Cell Lung Cancer, Immunotherapy	30	Netherlands	clinicaltrials.gov
September 8, 2026	NCT07807956	A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With...	AbbVie	Phase 1	Recruiting	Advanced Solid Tumors, Non-Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma, Gastric Cancer...	130	United States	clinicaltrials.gov
September 8, 2026	NCT07807722	Neoadjuvant Therapy With Firmonertinib Combined With Anlotinib and Platinum-Based Doublet Chemotherapy for Resectable EGFR-Mutated NSCLC	Hubei Cancer Hospital	Phase 2	Not yet recruiting	NSCLC (Non-small Cell Lung Cancer), EGFR, Neoadjuvant Therapy	29	China	clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
AstraZeneca	18	November 4, 2026
Bristol-Myers Squibb	18	October 13, 2026
Cancer Institute and Hospital, Chinese Academy of Medical Sciences	17	August 28, 2026
Sun Yat-sen University	16	October 20, 2026
Shanghai Pulmonary Hospital, Shanghai, China	15	August 10, 2026
Fudan University	14	September 16, 2026
Tianjin Medical University Cancer Institute and Hospital	13	November 4, 2026
Pfizer	12	October 29, 2026
West China Hospital	12	October 26, 2026
Peking University Cancer Hospital & Institute	11	October 26, 2026
Shanghai Chest Hospital	11	October 22, 2026
Peking University People's Hospital	9	October 21, 2026
The First Affiliated Hospital of Guangzhou Medical University	9	September 1, 2026
Memorial Sloan Kettering Cancer Center	8	June 2, 2026
Merck Sharp & Dohme LLC	8	April 28, 2026
European Institute of Oncology	7	November 2, 2026
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	7	October 22, 2026
Second Affiliated Hospital, Zhejiang University, School of Medicine	7	September 16, 2026
Guangdong Association of Clinical Trials	7	July 10, 2026
Tang-Du Hospital	6	November 5, 2026

By phase

Phase	New trials	Latest
Phase 2	275	November 5, 2026
Observational	214	November 9, 2026
Not applicable	143	November 6, 2026
Phase 1	130	November 6, 2026
Phase 1/2	101	November 3, 2026
Phase 3	88	November 2, 2026
Phase 2/3	17	October 22, 2026
Early phase 1	10	October 23, 2026
Phase 4	9	September 16, 2026

By country

Country	New trials	Latest
China	412	November 6, 2026
United States	260	November 3, 2026
Spain	92	October 13, 2026
Italy	88	November 2, 2026
France	88	October 29, 2026
Australia	75	October 14, 2026
South Korea	65	November 6, 2026
Canada	57	November 2, 2026
Japan	55	November 9, 2026
Germany	53	October 13, 2026
Taiwan	52	October 22, 2026
United Kingdom	52	October 13, 2026
Turkey (Türkiye)	47	July 31, 2026
Poland	42	October 13, 2026
Belgium	38	July 31, 2026
Netherlands	31	September 8, 2026
Greece	30	October 28, 2026
Brazil	30	July 31, 2026
Argentina	26	July 31, 2026
Romania	22	October 13, 2026
Switzerland	22	May 4, 2026
Austria	21	July 31, 2026
Israel	21	April 7, 2026
Hungary	20	August 3, 2026
Hong Kong	20	August 3, 2026

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.